EMTK:IDXPT Elang Mahkota Teknologi Tbk Analysis
Data as of 2026-07-22 - not real-time
IDR 540.00
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
EMTK is trading below its 50‑day and 200‑day moving averages, signalling a bearish longer‑term trend, yet it sits above the 20‑day SMA with a neutral RSI and a bullish MACD histogram, suggesting short‑term resilience. Volume has been tapering and 30‑day volatility is elevated, but the stock’s beta is very low and market sentiment is in the “Extreme Greed” zone, which could fuel a near‑term bounce.
Fundamentally, the company delivers robust revenue growth and a dividend yield near 2% with a high payout ratio, while its trailing PE sits well under the industry average and its price‑to‑book is below one, indicating a valuation gap. However, forward earnings are expected to collapse, pushing the forward PE sky‑high, and free cash flow is negative despite strong operating cash, highlighting execution risk. The DCF model values the shares at more than double the current price, but the high historical drawdown and regulatory exposure in the broadcasting sector temper the upside potential.
Fundamentally, the company delivers robust revenue growth and a dividend yield near 2% with a high payout ratio, while its trailing PE sits well under the industry average and its price‑to‑book is below one, indicating a valuation gap. However, forward earnings are expected to collapse, pushing the forward PE sky‑high, and free cash flow is negative despite strong operating cash, highlighting execution risk. The DCF model values the shares at more than double the current price, but the high historical drawdown and regulatory exposure in the broadcasting sector temper the upside potential.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- price above 20‑day SMA
- bullish MACD histogram
- neutral RSI
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- strong revenue growth
- trailing PE below industry average
- attractive dividend yield
Long Term
> 3 yearsPositive
Model confidence: 7/10
Key Factors
- DCF fair value indicating >100% upside
- sub‑1.0 price‑to‑book ratio
- substantial cash buffer despite high debt‑to‑equity
Key Metrics & Analysis
Financial Health
Revenue Growth47.60%
Profit Margin13.43%
P/E Ratio11.7
ROE9.00%
ROA1.19%
Debt/Equity4.51
P/B Ratio0.9
Op. Cash FlowIDR2101.4B
Free Cash FlowIDR-287386501120
Industry P/E16.0
Technical Analysis
TrendBearish
RSI49.9
SupportIDR 476.00
ResistanceIDR 565.00
MA 20IDR 516.70
MA 50IDR 574.48
MA 200IDR 943.50
MACDBullish
VolumeDecreasing
Fear & Greed Index90.98
Valuation
Fair ValueIDR 1,244.73
GradeUndervalued
TypeBlend
Dividend Yield1.82%
Risk Assessment
Beta0.14
Volatility48.41%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.